Position in CERS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$708,392
+$310,045 QoQ
Shares Held
242,600
+10.8% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 186 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,271,214,892 across 85 Medical Devices names. CERS ranks #45 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,820,543 | $255,936,071 | |
| 2 | SYK |
Stryker Corp
|
616,745 | $194,175,995 | |
| 3 | MDT |
Medtronic plc
|
2,213,044 | $173,126,432 | |
| 4 | BSX |
Boston Scientific Corp
|
2,641,843 | $112,753,859 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,096,770 | $99,213,814 | |
| 6 | DXCM |
Dexcom Inc
|
768,165 | $51,735,912 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
755,006 | $48,327,934 | |
| 8 | STE |
STERIS plc
|
217,541 | $45,807,608 |
All Filings in CERS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $708,392 | 242,600 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $398,347 | 218,872 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $472,537 | 229,387 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $428,582 | 269,549 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $379,213 | 268,946 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $350,150 | 251,907 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $367,744 | 238,795 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $400,786 | 230,337 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $444,301 | 252,444 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $456,822 | 241,705 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $505,122 | 233,853 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $379,710 | 234,389 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $578,609 | 235,207 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $680,320 | 229,064 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $805,058 | 220,564 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $776,372 | 215,659 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,058,798 | 200,151 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $972,059 | 177,060 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,336,959 | 196,323 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,214,711 | 199,460 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,143,685 | 193,517 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,247,189 | 207,519 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,518,102 | 219,379 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,339,521 | 213,981 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,596,843 | 241,946 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $887,103 | 190,775 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||